Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Walking intervention and dieta...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Walking intervention and dietary guidance efficacy for overweight people with schizophrenia: An open‐label 12‐week study

Walking intervention and dietary guidance efficacy for overweight people with schizophrenia: An open‐label 12‐week study

Bibliographic Details
Main Authors: Taro Kishi, Makoto Okuya, Kenji Sakuma, Yohei Otaka, Eiichi Saitoh, Nakao Iwata
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:PCN Reports
Online Access:https://doi.org/10.1002/pcn5.52
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://doi.org/10.1002/pcn5.52

Similar Items

  • Body composition in Japanese patients with psychiatric disorders: A cross‐sectional study
    by: Taro Kishi, et al.
    Published: (2021-03-01)
  • Lemborexant for insomnia in adults with psychiatric disorders: A 1‐week, open‐label study
    by: Taro Kishi, et al.
    Published: (2022-09-01)
  • Efficacy, tolerability, and safety of lurasidone for acute schizophrenia: A systematic review and network meta‐analysis of phase 3 trials in Japan
    by: Taro Kishi, et al.
    Published: (2020-09-01)
  • Outcomes of patients with schizophrenia who discontinued long‐acting injectable antipsychotic therapy due to adverse events: A chart review
    by: Taro Kishi, et al.
    Published: (2021-09-01)
  • Suvorexant for insomnia in patients with psychiatric disorder: A 1‐week, open‐label study
    by: Taro Kishi, et al.
    Published: (2019-09-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs